Commodore Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
4
- Investments
-
35
- Portfolio
-
11
- Exits
-
12
Commodore Capital General Information
Company Description
Founded in 2019, Commodore Capital is a venture capital firm based in New York, New York. The firm seeks to invest in the biopharmaceuticals sector. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.commodorecapital.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- 444 Madison Avenue
- 35th Floor
- New York, NY 10022
- United States
Commodore Capital Investments (35)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Crescent Biopharma | 16-Jun-2025 | PIPE | Drug Discovery | Generating Revenue | ||
| Neurogene | 05-Nov-2024 | Drug Discovery | Generating Revenue | |||
| Inhibikase Therapeutics | 21-Oct-2024 | Drug Discovery | Generating Revenue | |||
| IDRx | 05-Aug-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| MindMed (Pharmaceuticals and Biotechnology) | 30-Jun-2024 | Drug Discovery | Generating Revenue | |||
| Avalo Therapeutics | 28-Mar-2024 | Biotechnology | Generating Revenue/Not Profitable | |||
| Enliven Therapeutics | 21-Mar-2024 | Biotechnology | Generating Revenue/Not Profitable | |||
| enGene (Biotechnology) | 20-Feb-2024 | Biotechnology | Clinical Trials - General | |||
| Cogent Biosciences | 16-Feb-2024 | PIPE | Biotechnology | Generating Revenue | ||
| Adverum Biotechnologies | 08-Feb-2024 | PIPE | Biotechnology | Generating Revenue/Not Profitable |
Commodore Capital Exits (12)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Allakos | 15-May-2025 | Merger/Acquisition | |
| IDRx | 24-Feb-2025 | ||
| Arkive (Financial Services) | 01-Feb-2025 | ||
| Spyre Therapeutics | 19-Nov-2024 | ||
| Harpoon Therapeutics | 11-Mar-2024 | ||
| Akero Therapeutics | 06-Mar-2024 | ||
| SAb Biotherapeutics | 26-Jan-2024 | ||
| Satsuma Pharmaceuticals | 08-Jun-2023 | ||
| Kronos Bio | 09-Oct-2020 | IPO | |
| C4 Therapeutics | 02-Oct-2020 | IPO |
Commodore Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Commodore Capital Co-Investors (74)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| BVF Partners | 3 |
|
|
||
| RA Capital Management |
|
|
|||
| Atlas Venture |
|
|
|||
| Cormorant Asset Management |
|
|
|||
| OrbiMed |
|
|
Commodore Capital FAQs
-
What is Commodore Capital?
Founded in 2019, Commodore Capital is a venture capital firm based in New York, New York.
-
When was Commodore Capital founded?
Commodore Capital was founded in 2019.
-
Where is Commodore Capital headquartered?
Commodore Capital is headquartered in New York, NY.
-
What is Commodore Capital's total asset value?
Commodore Capital has around in total assets under management.
-
How many investments has Commodore Capital made?
Commodore Capital has made 35 investments.
-
What has Commodore Capital invested in?
Commodore Capital has made numerous investments in companies like Crescent Biopharma, Neurogene, and Inhibikase Therapeutics within the Drug Discovery industry.
-
What has Commodore Capital invested in recently?
Commodore Capital's latest investment was on 16-Jun-2025 in Crescent Biopharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
